Corporate and M&A boutique Hibiya-Nakata focuses on Japanese outbound and inbound M&A. It is regularly retained by major banks and leading corporations in Japan for high-profile outbound deals. Despite being a smaller-sized firm, Hibiya-Nakata prides itself on the quality of work provided, especially in cross-border M&A work. Key figures include Nobuo Nakata and Tatsuya Soeda.
Work highlights
Advised Dalton Investments, Nippon Active Value Fund (NAVF), and NAVF Select on the ¥32.1 billion ($222.6 million) sale of their 24.57% stake in T&K Toka to Bain Capital's SPV through a tender offer. The transaction involves a subsequent 15% reinvestment by the clients into Bain Capital's holding company, establishing a joint venture. This deal is notable for its structure, where a global private equity fund fully acquires a Japanese listed company for delisting, followed by the former largest foreign financial shareholder group joining as a minority shareholder post-delisting.
Advising Mitsubishi Chemical Corporation on the sale of its subsidiary, Mitsubishi Chemical Indonesia, to Lintas Citra Pratama. The deal is structured as a multi-step transaction, where Mitsubishi Chemical will divest all shares in its Indonesian subsidiary to Lintas Citra Pratama over a period of years. While the deal value remains undisclosed, the transaction is significant due to its complex, phased structure and its cross-border nature involving Japanese and Indonesian jurisdictions.
Key clients
Ichikoh Industries, IDAJ Holdings, Nippn Corporation, Yukon Capital Partners
